Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hostile takeovers: viral appropriation of the NF-kappaB pathway.

× No keyword cloud information.

46 in total

1. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors: B K Chen; M B Feinberg; D Baltimore
Journal: J Virol Date: 1997-07 Impact factor: 5.103

Review 2. The ER-overload response: activation of NF-kappa B.

Authors: H L Pahl; P A Baeuerle
Journal: Trends Biochem Sci Date: 1997-02 Impact factor: 13.807

3. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells.

Authors: S Kinoshita; L Su; M Amano; L A Timmerman; H Kaneshima; G P Nolan
Journal: Immunity Date: 1997-03 Impact factor: 31.745

4. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase.

Authors: G Briand; B Barbeau; M Tremblay
Journal: Virology Date: 1997-02-17 Impact factor: 3.616

5. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

Authors: P Roux; C Alfieri; M Hrimech; E A Cohen; J E Tanner
Journal: J Virol Date: 2000-05 Impact factor: 5.103

6. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.

Authors: S K Manna; B B Aggarwal
Journal: J Immunol Date: 2000-05-15 Impact factor: 5.422

7. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.

Authors: A D Yurochko; M W Mayo; E E Poma; A S Baldwin; E S Huang
Journal: J Virol Date: 1997-06 Impact factor: 5.103

8. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Authors: R E Jeeninga; M Hoogenkamp; M Armand-Ugon; M de Baar; K Verhoef; B Berkhout
Journal: J Virol Date: 2000-04 Impact factor: 5.103

Review 9. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

Authors: A Roulston; R Lin; P Beauparlant; M A Wainberg; J Hiscott
Journal: Microbiol Rev Date: 1995-09

10. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.

Authors: J Alcamí; T Laín de Lera; L Folgueira; M A Pedraza; J M Jacqué; F Bachelerie; A R Noriega; R T Hay; D Harrich; R B Gaynor
Journal: EMBO J Date: 1995-04-03 Impact factor: 11.598

235 in total

Review 1. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors: G Zhang; S Ghosh
Journal: J Clin Invest Date: 2001-01 Impact factor: 14.808

2. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors: G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal: EMBO J Date: 2001-12-03 Impact factor: 11.598

10. Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.

Authors: Soo-Ho Choi; Kyu-Jin Park; Byung-Yoon Ahn; Guhung Jung; Michael M C Lai; Soon B Hwang
Journal: Mol Cell Biol Date: 2006-04 Impact factor: 4.272

Hostile takeovers: viral appropriation of the NF-kappaB pathway.

1. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Review 2. The ER-overload response: activation of NF-kappa B.

3. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells.

4. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase.

5. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

6. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.

7. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.

8. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Review 9. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

10. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.

Review 1. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

2. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Review 3. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

4. The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Review 5. Resistance to TRAIL and how to surmount it.

Review 6. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

7. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs.

8. Therapeutic effects of fibroblast growth factor-10 on hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.

Review 9. T-cell control by human T-cell leukemia/lymphoma virus type 1.

10. Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase.